Anemia in chronic kidney disease
ICD-10 D63.1 is a billable code used to indicate a diagnosis of anemia in chronic kidney disease.
Anemia in chronic kidney disease (CKD) is a common complication that arises due to the kidneys' diminished ability to produce erythropoietin, a hormone crucial for red blood cell production. Patients with CKD often experience a reduction in red blood cell count, leading to symptoms such as fatigue, weakness, and pallor. The anemia associated with CKD is typically normocytic and normochromic, although it can also present as microcytic in some cases due to concurrent iron deficiency. The pathophysiology involves a combination of factors including decreased erythropoietin production, iron deficiency, and the effects of uremia on bone marrow function. Management of anemia in CKD often includes erythropoiesis-stimulating agents (ESAs) and iron supplementation, tailored to the patient's specific needs and underlying conditions. It is crucial for healthcare providers to monitor hemoglobin levels and iron status regularly to optimize treatment and improve patient outcomes.
Detailed documentation of kidney function, CKD stage, and anemia workup.
Patients with advanced CKD presenting with fatigue and low hemoglobin levels.
Monitoring for iron deficiency and response to ESA therapy.
Comprehensive evaluation of anemia type and underlying causes.
Patients with CKD referred for anemia management and treatment options.
Differentiating between CKD-related anemia and other hematologic disorders.
Used for routine hemoglobin level checks in CKD patients.
Document the reason for blood draw and patient history.
Nephrologists should ensure that lab results are linked to CKD management.
The primary cause of anemia in CKD is the reduced production of erythropoietin by the kidneys, leading to decreased red blood cell production.
